Skip to content

Clinical trials

Observational Growth Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Growth Disorders Phase: Observational Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20081
20091
20101
201110
20126
20133
20146
20154
20163
20172
20182
20194
20204
20219
20225
20234
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed53
Unknown status10
Recruiting7
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck KGaA, Darmstadt, Germany19
Assiut University4
Novo Nordisk A/S3
Bina Nusantara University2
Danone Asia Pacific Holdings Pte, Ltd.2
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Indonesia University2
Khyber Medical University Peshawar2
London School of Hygiene and Tropical Medicine2
Queen Mary University of London2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Growth Disorders75
Malnutrition10
Cachexia7
Obesity6
Thinness5
Anemia3
Anemia, Iron-Deficiency2
Child Nutrition Disorders2
Diarrhea2
Dwarfism2

Trials

Showing 51 to 75 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.